Based on the analysis of Danaher's profitability, liquidity, and operating efficiency, Danaher is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December. At this time, Danaher's Cash is relatively stable compared to the past year. As of 11/30/2024, Non Current Assets Total is likely to grow to about 74.1 B, while Common Stock Shares Outstanding is likely to drop slightly above 669.1 M. Key indicators impacting Danaher's financial strength include:
Investors should never underestimate Danaher's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Danaher's cash flow, debt, and profitability to make informed and accurate decisions about investing in Danaher.
Cash And Equivalents
5.8 Billion
Danaher
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change To Inventory
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Other Non Cash Items
Dividends Paid
Change To Account Receivables
Other Cashflows From Investing Activities
Stock Based Compensation
Total Cashflows From Investing Activities
Investments
Change Receivables
Net Borrowings
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Change To Liabilities
Change To Operating Activities
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Intangible Assets
Accounts Payable
Common Stock Total Equity
Common Stock
Other Liab
Other Assets
Long Term Debt
Good Will
Property Plant Equipment
Current Deferred Revenue
Total Permanent Equity
Noncontrolling Interest In Consolidated Entity
Retained Earnings Total Equity
Additional Paid In Capital
Deferred Long Term Liab
Preferred Stock Total Equity
Net Tangible Assets
Long Term Debt Total
Capital Surpluse
Long Term Investments
Non Current Liabilities Other
Short Long Term Debt
Cash And Equivalents
Net Invested Capital
Net Working Capital
Capital Stock
Capital Lease Obligations
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Research Development
Net Income Applicable To Common Shares
Net Income From Continuing Ops
Non Operating Income Net Other
Discontinued Operations
Minority Interest
Tax Provision
Interest Income
Extraordinary Items
Net Interest Income
Reconciled Depreciation
Preferred Stock And Other Adjustments
Probability Of Bankruptcy
Understanding current and past Danaher Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Danaher's financial statements are interrelated, with each one affecting the others. For example, an increase in Danaher's assets may result in an increase in income on the income statement.
Danaher competes with Agilent Technologies, Illumina, IDEXX Laboratories, Waters, and Thermo Fisher. Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. Danaher Corp operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 78000 people.
The reason investors look at the income statement is to determine what Danaher's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Danaher's current stock value. Our valuation model uses many indicators to compare Danaher value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Danaher competition to find correlations between indicators driving Danaher's intrinsic value. More Info.
Danaher is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Danaher is roughly 1.97 . At this time, Danaher's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Danaher by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Danaher Systematic Risk
Danaher's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Danaher volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Danaher correlated with the market. If Beta is less than 0 Danaher generally moves in the opposite direction as compared to the market. If Danaher Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Danaher is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Danaher is generally in the same direction as the market. If Beta > 1 Danaher moves generally in the same direction as, but more than the movement of the benchmark.
Danaher Thematic Clasifications
Danaher is part of several thematic ideas from Measuring and Control Equipment to Healthcare. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Danaher Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Danaher's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Danaher growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Danaher help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Danaher. We use our internally-developed statistical techniques to arrive at the intrinsic value of Danaher based on widely used predictive technical indicators. In general, we focus on analyzing Danaher Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Danaher's daily price indicators and compare them against related drivers.
When running Danaher's price analysis, check to measure Danaher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Danaher is operating at the current time. Most of Danaher's value examination focuses on studying past and present price action to predict the probability of Danaher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Danaher's price. Additionally, you may evaluate how the addition of Danaher to your portfolios can decrease your overall portfolio volatility.